TABLE 2.
Susceptibility of bacterial isolate DS15158 to antimicrobial agents
| Antimicrobial agent | MIC (μg/ml)a | Disk diffusion result | Etest MIC (μg/μl) |
|---|---|---|---|
| Levofloxacin | 4 | ||
| Ofloxacin | 8 | ||
| Ciprofloxacin | 4 | ||
| Meropenem | 2 | ||
| Imipenem | 2 | ||
| Ceftriaxone | >32 | ||
| Cefotaxime | >32 | ||
| Cefipime | >32 | ||
| Ceftazidime | >32 | ||
| Ticarcillin-clavulanate | >128/2b | ||
| Piperacillin-tazobactam | >128/4b | ||
| Ampicillin-sulbactam | >32/16b | ||
| Vancomycin | >16 | ||
| Oxacillin | 1 | Rc | >256 |
| Doxycycline | 16 | ||
| Amikacin | 32 | ||
| Tobramycin | R | ||
| Gentamicin | R | ||
| Polymyxin B | R | ||
| Colistin | R |
a
Broth microdilution method, inoculum of 1.5 × 105 CFU/ml, 24 h of incubation.
b
Beta-lactam antibiotic–beta-lactamase inhibitor concentration.
c
R, growth occurred up to the disk.